Key points from article :
UEA has developed nanoparticles that can deliver drugs directly to a tumour.
Able to deliver combination of docetaxel and fingolimod.
Less of the drug is needed to kill off the cancer cells.
Nanoparticles can be monitored using an MRI scan.
Mass production capability confirmed with Precision NanoSystems’ NanoAssemblr.
Close to entering clinical trials.
